Long Focus Capital Management, LLC Standard Biotools Inc. Call Options Transaction History
Long Focus Capital Management, LLC
- $2.17 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LAB
# of Institutions
166Shares Held
278MCall Options Held
34.9KPut Options Held
0-
Casdin Capital, LLC New York, NY76.1MShares$97.4 Million12.8% of portfolio
-
Viking Global Investors LP58.7MShares$75.1 Million0.22% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$27.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$21.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA7.44MShares$9.52 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $101M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...